FTDZX Mutual Fund (Franklin Biotechnology Discovery Fund Advisor Class) is managed by Franklin Templeton Investments (US) with $154.0M in net assets. FTDZX expense ratio is 0.77%, holding 98 positions across sectors including Health Care, Unknown, Financials. Inception date: 2009-09-01.

FTDZX performance shows a YTD return of 18.46%. The 1-year return is 91.39% and the 5-year return is 12.10%. FTDZX dividend yield stands at 1.81%, paid annually.

FTDZX top holdings include Gilead Sciences Inc (6.2%), Amgen Inc. (4.8%), Nvaesrtex Pharmaceuticals Inc (4.7%), Jazz Pharmaceuticals Plc. (4.6%), Regeneron Pharmaceuticals, Inc. (4.4%). View all FTDZX holdings, sector breakdown, or dividend history.

FTDZX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FTDZX alternatives are available via the screener, along with tax-loss harvesting opportunities.